Hoggar (Doxylamine Hydrogen Succinate)

Hoggar is commonly used to manage several conditions where histamine release contributes to symptoms. Its antihistamine and sedative properties make it suitable for short‑term relief of the following:

• Relief of occasional insomnia or difficulty falling asleep.
• Temporary alleviation of allergic rhinitis symptoms such as sneezing, runny nose, and itchy eyes.
• Reduction of nasal congestion and watery discharge associated with the common cold.
• Management of mild itching or hives caused by allergic reactions.
• Support for nighttime comfort when cold symptoms interfere with sleep.

• Doxylamine hydrogen succinate acts as a competitive antagonist at peripheral and central histamine H1 receptors. By blocking H1 receptor activation, it prevents the intracellular cascade that leads to vasodilation, increased vascular permeability, and neuronal excitation. The central H1 blockade also produces sedation by reducing histaminergic wake‑promoting activity in the brain, which contributes to its sleep‑inducing effect.

Like other first‑generation antihistamines, doxylamine may cause a range of adverse reactions, most of which are mild and transient.

Common

• Drowsiness or feeling of sedation.
• Dry mouth, throat, or nasal passages.
• Dizziness or light‑headedness.
• Blurred vision.
• Constipation or difficulty urinating.

Serious

• Severe allergic reaction (rash, itching, swelling, difficulty breathing).
• Rapid or irregular heartbeat.
• Confusion or hallucinations, especially in older adults.
• Persistent vomiting or severe gastrointestinal upset.

Before using Hoggar, consider the following safety points to minimize risks and ensure appropriate use.

• Avoid use if you have known hypersensitivity to doxylamine or other first‑generation antihistamines.
• Do not combine with alcohol, sedatives, or other CNS depressants, as additive drowsiness may occur.
• Use caution when driving, operating machinery, or performing tasks requiring alertness.
• Pregnant or breastfeeding individuals should consult a healthcare professional before use.
• Elderly patients may be more susceptible to sedation and anticholinergic effects; start with the lowest effective dose.
• Individuals with glaucoma, enlarged prostate, or urinary retention should discuss use with a clinician.

Doxylamine can affect the activity of several other medicines; be aware of the following potential interactions.

Avoid

• Alcohol or other central nervous system depressants (e.g., benzodiazepines, opioids, barbiturates).
• Monoamine oxidase inhibitors (MAOIs) or recent MAOI therapy.
• Other antihistamines or sleep aids taken concurrently.

Use with caution

• Anticholinergic drugs (e.g., tricyclic antidepressants, antipsychotics) which may increase dry‑mouth or urinary retention.
• CNS stimulants (e.g., caffeine, modafinil) that may counteract sedative effects.
• Medications metabolized by CYP2D6, as doxylamine may inhibit this pathway.